Abstract
The behavioral effects of racemic mianserin, its (+) and (−) enantiomers, and its metabolites desmethylmianserin and 8-hydroxymianserin were evaluated on the differential-reinforcement-of-low-rate 72-s (DRL 72-s) schedule, a screen known to be sensitive to and specific for the antidepressant properties of drugs. Racemic mianserin produced the antidepressant-like effect (increased reinforcement rate, decreased response rate) at 5 and 10 mg/kg. The mianserin enantiomers showed the antidepressant-like effect beginning at lower doses [(+) mianserin; 0.6 mg/kg; (−) mianserin: 2.5 mg/kg]. The mianserin metabolites showed no clear dose-related effect at doses up to 10 mg/kg. It is concluded that the antidepressant-like effects of mianserin are due to the activity of the parent compound rather than to its metabolites, and that they may be primarily attributable to the (+) enantiomer. The greater potency of (+)-mianserin may be related to its higher affinity for the 5-HT2 receptor.
Similar content being viewed by others
References
Baumann PA, Maitre L (1977) Blockade of presynaptic alpha receptors and of amine uptake in the rat brain by the antidepressant mianserin. Naunyn-Schmiedebergs Arch Pharmacol 300:31–37
Britton KT, Koob GF (1989) Effects of corticotropin releasing factor, desipramine and haloperidol on a DRL schedule of reinforcement. Pharmacol Biochem Behav 32:967–970
Conn PJ, Sanders-Bush E (1986) Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT2 binding site. J Neurosci 6:3669–3675
Conn PJ, Sanders-Bush E, Hoffman BJ, Hartig PR (1986) A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc Nat Acad Sci USA 83:4086–4088
Danysz W, Plazni A, Kostowski W, Malatynska E, Jarbe TUC, Hiltunen AJ, Archer T (1988) Comparison of desipramine, amitriptyline, zimelidine and alaproclate in six animal models used to investigate antidepressant drugs. Pharmacol Toxicol 62:42–50
Dumbrille-Ross A, Tang SW, Seeman P (1980) High affinity binding of [3H]mianserin to rat cerebral cortex. Eur J Pharmacol 68:395–396
Fell PJ, Quantock DC, van der Burg WJ (1973) The human pharmacology of GB 94-A new psychotropic agent. Eur J Clin Pharmacol 5:161–173
Ghose K, Coppen A, Turner P (1976) Autonomic actions and interactions of mianserin hydrochloride (Org GB 94) and amitriptyline in patients with depressive illness. Psychopharmacology 49:201–204
Hoppenbrowers ML, Gelders Y, Vanden Bussche G (1986) Ritan-serin (R 55667) an original thymosthenic. Bull Chim Farm 125:136S-147S
Howard JL, Pollard GT (1984) Effects of imipramine, bupropion, chlorpromazine and clozapine on differential-reinforcement-of-low-rate (DRL)>72-s and >36-s schedules in rat. Drug Dev Res 4:607–616
Howard JL, Soroko FE, Cooper BR (1981) Empirical behavioral models of depression with emphasis on tetrabenazine antagonism. In: Enna SJ et al. (eds) Antidepressants: neurochemical, behavioral and clinical perspectives. Raven Press, New York, pp 107–120
Itil TM (1981) The discovery of psychotropic drugs by computeranalyzed cerebral biopotentials (CEEG). Drug Dev Res 1:373–407
Jancsar SM, Leonard BE (1984) The effect of (±)mianserin and its enantiomers on the behavioral hyperactivity of the olfactory-bulbectomized rat. Neuropharmacology 23:1065–1070
Jongh GD de, Wildenberg HM, van de, Nieuwenhuyse H, Veen F van der (1981) The metabolism of mianserin in women, rabbits and rats. Identification of the major urinary metabolites. Drug Metab Dispos 9:48–53
Kennett GA, Curzon G (1988) Evidence that mCPP may have behavioral effects mediated by central 5-HT1C receptors. Br J Pharmacol 94:137–147
Kennett GA, Whitton P, Shah K, Curzon G (1989) Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol 164:445–454
Leonard BE (1974) Some effects of a new tetracyclic antidepressant compound, Org GB 94, on the metabolism of monoamines in the rat bain. Psychopharmacologia 36:221–236
Leysen JE, Niemegeers CJE, Van Nueten JM, Laduron PM (1982) Ketanserin (R 41 468), a selective3H-ligand for serotonin2 receptor binding sites. Mol Pharmacol 21:301–314
Li AA, Marek GJ, Vosmer G, Seiden LS (1989) Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Pharmacol Biochem Behav 33:641–648
Li AA, Marek GJ, Hand TH, Seiden LS (1990) Antidepressant-like effects of trazodone on a behavioral screen are mediated by trazodone, not the metabolite m-chlorophenylpiperazine. Eur J Pharmacol 277:137–144
Luttinger D, Freedman M, Hamel L, Ward SJ, Perrone M (1985) The effects of serotonin antagonists in a behavioral despair procedure in mice. Eur J Pharmacol 1097:53–58
Maitre L, Bouman PA, Jackel J, Waldmeier PC (1982) 5-HT uptake inhibitors: psychopharmacological and neurobiological criteria of selectivity. In: Ho BT et al. (eds) Serotonin in biological psychiatry. Raven Press, New York
Maj J, Sowinska H, Baran L, Gancarczyk L, Rawlow A (1978) The central antiserotonergic action of mianserin. Psychopharmacology 59:79–84
Marek GJ, Seiden LS (1988a) Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-sec schedule. J Pharmacol Exp Ther 244:650–658
Marek GJ, Seiden LS (1988b) Selective inhibition of MAO-A not MAO-B results in antidepressant-like effects on DRL 72-s behavior. Psychopharmacology 96:153–160
Marek GJ, Li A, Seiden LS (1988) Antidepressant-like effects of (+)-oxaprotiline on a behavioral screen. Eur J Pharmacol 157:183–188
Marek GJ, Li AA, Seiden LS (1989a) Selective 5-hydroxytryptamine-2 antagonists have antidepressant-like effects on the differential-reinforcement-of-low-rate 72-s schedule. J Pharmacol Exp Ther 250:52–59
Marek GJ, Li A, Seiden LS (1989b) Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-s behavior. J Pharmacol Exp Ther 250:60–71
Nickolson VJ, Wieringa JH, Delft AML van (1982) Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin. Naunyn Schmiedeberg's Arch Pharmacol 319:48–55
O'Donnell JM (1987) Effects of clenbuterol and prenalterol on performance during differential-reinforcement-of-low-rate response rate in the rat. J Pharmacol Exp Ther 241:68–75
O'Donnell JM, Seiden LS (1982) Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate. Psychopharmacology 78:214–218
O'Donnell JM, Seiden LS (1983) Differential-reinforcement-of-low-rate 72-second schedule: selective effects of antidepressant drugs. J Pharmacol Exp Ther 224:80–88
Peroutka SJ, Snyder S (1981) [3H]Mianserin: differential labeling of serotonin2 and histamine1 receptors in rat brain. J Pharmacol Exp Ther 216:142
Pinder RM (1985) Adrenoceptor interactions of the enantiomers and metabolites of mianserin: are they responsible for the anti-depressant effect? Acta Psychiatr Scand 72 [suppl 320]:1–9
Pinder RM, Fink M (1982) Pharmacological aspects of mianserin Acta Psychiatr Scand Suppl 302:59–71
Pinder RM, van Delft AML (1983) The potential therapeutic role of the enantiomers and metabolites of mianserin. Br J Clin Pharmacol 15:269S-276S
Pollard GT, Howard JL (1986) Similar effects of antidepressant and non-antidepressant drugs on behavior under an interresponse-time >72-s schedule. Psychopharmacology 89:253–258
Porsolt RD, LePichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730–732
Randrup A, Braestrup C (1977) Uptake inhibition of biogenic amines by newer antidepressant drugs. Psychopharmacologia 53:309–314
Richelson E (1979) Tricyclic antidepressants and histamine H1 receptors. Mayo Clin Proc 54:669–674
Sanders-Bush E, Breeding M, Roznoski M (1987) 5-HT2 binding sites after mianserin: comparison of loss of sites and brain levels of drug. Eur J Pharmacol 133:199–204
Sanders-Bush E, Breeding M, Knoth K Tsutsumi M (1989) Sertraline-induced desensitization of the serotonin 5-HT2 receptor transmembrane signaling system. Psychopharmacology 99:64–69
Sanger DJ (1988) The alpha2-adrenoceptor antagonists idazoxan and yohimbine increase rates of DRL responding in rats. Psychopharmacology 95:413–417
Schoemaker H, Berendsen HHG, Stevens HJV, Nickolson VJ (1981) Differences in presynaptic alpha-blockade, noradrenaline uptake inhibition and potential antidepressant activity between (+)- and (−)-mianserin. Psychopharmacology 74:137–142
Seiden LS, Dahms JL, Shaughnessy RA (1985) Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule. Psychopharmacology 86:55–60
Snapper AG, Stephens KR, Cobez RI, Van Haaren FC (1976) The SKED software systems: OS8 and time share. State Systems, Kalamazoo
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hand, T.H., Marek, G.J. & Seiden, L.S. Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity. Psychopharmacology 105, 453–458 (1991). https://doi.org/10.1007/BF02244363
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244363